Q4 2022 Holdings
Filed 2023-02-14 | 9 holdings | $239.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $59.8M | 4,425,784 | 25.0% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $57.4M | 4,951,303 | 24.0% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $53.5M | 2,738,785 | 22.4% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $33.0M | 2,242,636 | 13.8% |
| Amryt Pharma plc | Common | 03217L106 | $19.5M | 2,668,843 | 8.2% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $8.8M | 4,284,172 | 3.7% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $4.0M | 4,050,865 | 1.7% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $2.3M | 3,131,388 | 1.0% |
| Oncorus, Inc. | Common | 68236R103 | $720.9K | 2,849,464 | 0.3% |